TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Ireland suspends AstraZeneca jab over blood clot fears
The move came after Ireland's National Immunisation Advisory Committee (NIAC) recommended suspending the AstraZeneca rollout "on the precautionary principal" after "a report from the Norwegian Medicines Agency of four new reports of serious blood clotting events in adults after vaccination".
Change Size
Britain's Prime Minister Boris Johnson poses for a photograph with a vial of the AstraZeneca/Oxford University COVID-19 candidate vaccine, known as AZD1222, at Wockhardt's pharmaceutical manufacturing facility in Wrexham, Wales, Britain November 30, 2020. (REUTERS/Paul Ellis/Pool )
Ireland suspended the use of the AstraZeneca coronavirus vaccine on Sunday, following reports of blood clots in adults who received the shot in Norway.
"The administration of COVID-19 Vaccine AstraZeneca is temporarily deferred from this morning, Sunday 14th March," a health ministry spokesman told AFP.
The move came after Ireland's National Immunisation Advisory Committee (NIAC) recommended suspending the AstraZeneca rollout "on the precautionary principal" after "a report from the Norwegian Medicines Agency of four new reports of serious blood clotting events in adults after vaccination".
"It has not been concluded that there is any link" between the AstraZeneca vaccine and the blood clot cases and action has been taken "pending receipt of further information", Ireland's deputy chief medical officer Ronan Glynn said in a statement.
The NIAC is due to meet on Sunday morning and to issue a further statement on the matter.
Some 570,000 doses of coronavirus vaccines have been administered in Ireland to date, according to government data last updated Wednesday.
A total of 109,000 of those doses have been manufactured by the Anglo-Swedish pharma giant AstraZeneca.
An AstraZeneca spokesman said the "an analysis of our safety data that covers reported cases from more than 17 million doses of vaccine administered has shown no evidence of an increased risk" in blood clot conditions.
"In fact, the reported numbers of these types of events for COVID-19 Vaccine AstraZeneca are lower than the number that would have occurred naturally in the unvaccinated population," a statement added.
Ireland -- a nation of five million -- has suffered 4,534 deaths from the coronavirus according to latest official figures.
The Republic is currently in the midst of its third lockdown after suffering a surge of cases which saw it become the world's most infectious nation in early January.
The government is already under pressure from opposition lawmakers over a drought in vaccine supply amid a sluggish nationwide rollout tethered to the EU jabs programme.
On Thursday health minister Stephen Donnelly said AstraZeneca is "repeatedly changing its delivery schedules, often at the last minute, and revising down the volumes it will deliver".
"It is deeply frustrating for everybody, with so many people looking to get vaccinated as quickly as possible," he told lawmakers in Ireland's Dail lower house of parliament.
